The objective of this study was to conduct a survey of the opinions and practices of gastroenterologists in the United Kingdom concerning the impact of Helicobacter pylori infection on the management of upper gastrointestinal diseases.
A postal questionnaire was sent to all medically qualified members of the British Society of Gastroenterology working in the UK.
Replies were received from 670 of 1037 eligible BSG members (65%). Of these, 73% thought that H pylori was a cause of duodenal ulcer and 84% thought that eradication of H pylori decreased ulcer recurrence in comparison with acid suppression.
While 80% used anti-H pylori therapy for a chronic relapsing duodenal ulcer, only 25% used such therapy for an ulcer at first presentation and 17% never used anti-H pylori therapy for patients with duodenal ulcer.
Although 75% of respondents did not agree that H pylori was a cause of non-ulcer dyspepsia, 69% used anti-H pylori therapy to treat a patient with this condition.
At the time of the survey, 69% of those who used anti-H pylori therapy adopted some variant of standard triple therapy.
In conclusion, at the time of the survey, the use of anti-H pylori therapy had been accepted by a majority of specialist UK gastroenterologists in the management of upper gastrointestinal disease.
There was, however, a substantial degree of uncertainty and divergence about which patients should be treated.
Mots-clés Pascal : Infection, Helicobacter pylori, Influence, Maladie, Gastrointestinal, Médecin, Gastroentérologie, Etude générale, Homme, Royaume Uni, Spirillaceae, Spirillales, Bactérie, Europe, Appareil digestif pathologie, Bactériose
Mots-clés Pascal anglais : Infection, Helicobacter pylori, Influence, Disease, Gastrointestinal, Physician, Gastroenterology, General study, Human, United Kingdom, Spirillaceae, Spirillales, Bacteria, Europe, Digestive diseases, Bacteriosis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0503367
Code Inist : 002B30A01A2. Création : 01/03/1996.